Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
Gilead Sciences(GILD) stock is priced at $139.72, giving the company a market capitalization of 173.36B. It carries a P/E multiple of 21.83 and pays a dividend yield of 2.2%.
On 2026-01-28, Gilead Sciences(GILD) stock moved within a range of $138.69 to $140.99. With shares now at $139.72, the stock is trading +0.7% above its intraday low and -0.9% below the session's peak.
Trading activity shows a volume of 7.32M, compared to an average daily volume of 8.78M.
The stock's 52-week range extends from a low of $93.37 to a high of $141.71.
The stock's 52-week range extends from a low of $93.37 to a high of $141.71.
GILD News
Gilead Sciences reported that Trodelvy combined with Keytruda produced significantly improved progression free survival in first line treatment of advanced PD L...
Gilead Sciences announced that The New England Journal of Medicine has published full Phase 3 ASCENT-04/KEYNOTE-D19 results, showing Trodelvy plus Keytruda impr...
Gilead Sciences (GILD) is back in focus after detailed Phase 3 ASCENT-04/KEYNOTE-D19 results in The New England Journal of Medicine showed that Trodelvy plus Ke...
Analyst ratings
76%
of 29 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.